As the COVID-19 pandemic has altered our everyday lives and challenged the medical community in profound ways, it’s a particularly apt moment to applaud the inspiring efforts of nurses across the St. Louis region. They consistently exhibit selfless care, compassion, and service.
It all started with genetic data. A gene here, a gene there. Eventually the story became clearer: If scientists are to one day find a cure for Alzheimer’s disease, they should look to the immune system. Over the past couple decades, researchers have identified numerous genes involved in various immune system functions that may also […]
The Alzheimer’s Association, with GHR Foundation and Edward Jones, announced a $14 million commitment in support of Washington University’s Dominantly Inherited Alzheimer’s Network Trials Unit (DIAN-TU) Primary Prevention Trial.
Kellie Carr and her 13-year-old son, Daniel, sat in the waiting room of a pediatric neurology clinic for yet another doctor’s appointment in 2012. For years, she struggled to find out what was causing his weakened right side. It wasn’t an obvious deficit, by any means, and anyone not paying close attention would see a […]
Beau M. Ances, MD, PhD, the Daniel J. Brennan Professor of Neurology at Washington University School of Medicine in St. Louis, recently received the Shining Star Award from the Down Syndrome Association of Greater St. Louis. Ances was recognized for his work championing the health and well-being of the Down syndrome community through his research […]
Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10% of patients surviving longer than five years after diagnosis.
Doug Lindsay had just started his senior year studying biochemistry at Kansas City’s Rockhurst College in 1999 when he was struck by the same mysterious disease that had left his mother bedridden — and doctors stumped.
Washington University School of Medicine in St. Louis is launching an international clinical trial aimed at preventing Alzheimer’s disease in people genetically destined to develop the illness at a young age. Unlike most other Alzheimer’s prevention trials, this one will enroll people before the disease has taken hold — up to 25 years before the […]
Longtime St. Louis benefactor Joanne Knight has committed up to $11.5 million to Washington University School of Medicine in St. Louis to support an innovative clinical trial aimed at preventing Alzheimer’s disease by treating people before the first signs of the illness appear in the brain.
The burden of Alzheimer’s disease doesn’t fall on all communities equally. Black Americans face about double the risk of developing the devastating neurodegenerative disease than non-Hispanic white Americans do.